Business

Conavi Medical to Showcase FDA-Cleared Hybrid Imaging System at TCT 2026

Financial Post · October 15, 2026 at 7:54 a.m.

This will be Conavi’s first TCT conference since receiving U.S.

Food and Drug Administration (FDA) 510(k) clearance for its next-generation hybrid intravascular ultrasound (IVUS) and optical coherence tomography (OCT) imaging system.

Conavi will showcase the cleared system alongside an expanded scientific and educational program featuring a podium case presentation, a new preclinical abstract and participation in two CRF Imaging Lab sessions.

Read the full article on Financial Post ›

5News aggregated this summary from the outlet’s public feed. The full article, with all the context, is on financialpost.com — the content belongs to Financial Post.

Conavi Medical to Showcase FDA-Cleared Hybrid Imaging System at TCT 2026

More from Financial Post

Nest Wealth Asset Management Appoints Sean Tascatan as Chief Investment and Growth Officer as It Enters Its Next Phase of Evolution

Body of Waves, a New Artwork Only at teamLab Planets TOKYO, Unveiled

Tropic Grows Bookings 70% Year Over Year, Marking Sixth Straight Quarter of Sequential Growth

Thunder Bay Library Workers Begin Strike to Defend Jobs and Public Services: ‘We’re Prepared to Fight for as Long as It Takes’

More in Business

Nest Wealth Asset Management Appoints Sean Tascatan as Chief Investment and Growth Officer as It Enters Its Next Phase of Evolution

Body of Waves, a New Artwork Only at teamLab Planets TOKYO, Unveiled

Tropic Grows Bookings 70% Year Over Year, Marking Sixth Straight Quarter of Sequential Growth

Thunder Bay Library Workers Begin Strike to Defend Jobs and Public Services: ‘We’re Prepared to Fight for as Long as It Takes’

National Comedy Center Preserves Hundreds of Rare, Never-Before-Seen I Love Lucy Behind-the-Scenes Photographs and Early Pilot Script for 75th Anniversary

Samsung Canada Launches Ask Us Anything to Answer Canadians’ Questions About Foldable Phones